Literature DB >> 18970673

Chiral separations of piperidine-2,6-dione analogues on Chiralpak IA and Chiralpak IB columns by using HPLC.

Imran Ali1, Lahoucine Naim, Ashraf Ghanem, Hassan Y Aboul-Enein.   

Abstract

Recently, two new immobilized polysaccharides based CSPs, namely tris-(3,5-dimethylphenylcarbamate) derivatives of amylose and cellulose known as Chiralpak IA and Chiralpak IB were introduced, which may be used with a wide range of solvents including standard and prohibited ones. Several racemic piperidine-2,6-dione analogues [aminoglutethimide, p-nitro-glutethimide, p-nitro-5-aminoglutethimide, cyclohexylaminoglutethimide, phenglutarimide and thalidomide] have been resolved on Chiralpak IA and Chiralpak IB columns (25cmx0.46cm). The non-conventional mobile phases used were methyl-tert-butyl ether-THF (90:10, v/v) [I], 100% dichloromethane [II] and 100% acetonitrile [III] separately at a flow rate of 1.0mL/min using a UV detector at 254nm. The resolution factors for Chiralpak IA and Chiralpak IB columns were 1.00-5.33 and 0.33-0.67, respectively. Chiralpak IA column gave better results than Chiralpak IB column for the reported molecules using the developed HPLC conditions. Experimental conditions and the possible chiral recognition mechanisms have been discussed.

Entities:  

Year:  2006        PMID: 18970673     DOI: 10.1016/j.talanta.2005.12.004

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  4 in total

1.  Biogenesis of ZnO nanoparticles using Pandanus odorifer leaf extract: anticancer and antimicrobial activities.

Authors:  Afzal Hussain; Mohammad Oves; Mohamed F Alajmi; Iqbal Hussain; Samira Amir; Jahangeer Ahmed; Md Tabish Rehman; Hesham R El-Seedi; Imran Ali
Journal:  RSC Adv       Date:  2019-05-16       Impact factor: 4.036

2.  Chiral Recognition Mechanisms of four β-Blockers by HPLC with Amylose Chiral Stationary Phase.

Authors:  Dongmei Wang; Fang Li; Zhen Jiang; Li Yu; Xingjie Guo
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

3.  Eco-friendly UPLC-MS/MS analysis of possible add-on therapy for COVID-19 in human plasma: Insights of greenness assessment.

Authors:  Omnia A El-Naem; Sarah S Saleh
Journal:  Microchem J       Date:  2021-04-02       Impact factor: 4.821

4.  Characteristic and complementary chiral recognition ability of four recently developed immobilized chiral stationary phases based on amylose and cellulose phenyl carbamates and benzoates.

Authors:  Takafumi Onishi; Takunori Ueda; Kenichi Yoshida; Kosuke Uosaki; Hiroyuki Ando; Ryota Hamasaki; Atsushi Ohnishi
Journal:  Chirality       Date:  2022-04-12       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.